{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T18:34:36Z","timestamp":1789842876086,"version":"4.0.1"},"reference-count":43,"publisher":"BMJ","issue":"4","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Med Genet"],"accepted":{"date-parts":[[2017,12,29]]},"published-print":{"date-parts":[[2018,4]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The aim of this guideline is to provide updated recommendations for Canadian genetic counsellors, medical geneticists, maternal fetal medicine specialists, clinical laboratory geneticists and other practitioners regarding the use of chromosomal microarray analysis (CMA) for prenatal diagnosis. This guideline replaces the 2011 Society of Obstetricians and Gynaecologists of Canada (SOGC)-Canadian College of Medical Geneticists (CCMG) Joint Technical Update.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A multidisciplinary group consisting of medical geneticists, genetic counsellors, maternal fetal medicine specialists and clinical laboratory geneticists was assembled to review existing literature and guidelines for use of CMA in prenatal care and to make recommendations relevant to the Canadian context. The statement was circulated for comment to the CCMG membership-at-large for feedback and, following incorporation of feedback, was approved by the CCMG Board of Directors on 5 June 2017 and the SOGC Board of Directors on 19 June 2017.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results and conclusions<\/jats:title>\n                    <jats:p>Recommendations include but are not limited to: (1) CMA should be offered following a normal rapid aneuploidy screen when multiple fetal malformations are detected (II-1A) or for nuchal translucency (NT) \u22653.5\u2009mm (II-2B) (recommendation 1); (2) a professional with expertise in prenatal chromosomal microarray analysis should provide genetic counselling to obtain informed consent, discuss the limitations of the methodology, obtain the parental decisions for return of incidental findings (II-2A) (recommendation 4) and provide post-test counselling for reporting of test results (III-A) (recommendation 9); (3) the resolution of chromosomal microarray analysis should be similar to postnatal microarray platforms to ensure small pathogenic variants are detected. To minimise the reporting of uncertain findings, it is recommended that variants of unknown significance (VOUS) smaller than 500\u2009Kb deletion or 1\u2009Mb duplication not be routinely reported in the prenatal context. Additionally, VOUS above these cut-offs should only be reported if there is significant supporting evidence that deletion or duplication of the region may be pathogenic (III-B) (recommendation 5); (4) secondary findings associated with a medically actionable disorder with childhood onset should be reported, whereas variants associated with adult-onset conditions should not be reported unless requested by the parents or disclosure can prevent serious harm to family members (III-A) (recommendation 8).<\/jats:p>\n                    <jats:p>The working group recognises that there is variability across Canada in delivery of prenatal testing, and these recommendations were developed to promote consistency and provide a minimum standard for all provinces and territories across the country (recommendation 9).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jmedgenet-2017-105013","type":"journal-article","created":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T12:15:53Z","timestamp":1519906553000},"page":"215-221","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":103,"title":["Practice guideline: joint CCMG-SOGC recommendations for the use of chromosomal microarray analysis for prenatal diagnosis and assessment of fetal loss in Canada"],"prefix":"10.1136","volume":"55","author":[{"given":"Christine M","family":"Armour","sequence":"first","affiliation":[{"name":"Department of Genetics, Children\u2019s Hospital of Eastern and Children\u2019s Hospital of Eastern Ontario Research Institute, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelley Danielle","family":"Dougan","sequence":"additional","affiliation":[{"name":"BORN Ontario, Children\u2019s Hospital of Eastern Ontario, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo-Ann","family":"Brock","sequence":"additional","affiliation":[{"name":"Departments of Obstetrics and Gynecology, Dalhousie University Medical School, Halifax, Nova Scotia, Canada"},{"name":"Department of Laboratory Medicine, Dalhousie University Medical School, Halifax, Nova Scotia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radha","family":"Chari","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of Alberta, Edmonton, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernie N","family":"Chodirker","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Child Health, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada"},{"name":"Department of Biochemistry and Medical Genetics, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"DeBie","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics and Core Molecular Diagnostic Laboratory, McGill University Health Centre, McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane A","family":"Evans","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Medical Genetics, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William T","family":"Gibson","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada"},{"name":"Department of Medical Genetics, BC Children\u2019s Hospital Research Institute, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Kolomietz","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya N","family":"Nelson","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada"},{"name":"Department of Pathology and Laboratory Medicine, BC Children\u2019s and BC Women\u2019s Hospitals, Vancouver, British Columbia, Canada"},{"name":"Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9rique","family":"Tihy","sequence":"additional","affiliation":[{"name":"Service de G\u00e9n\u00e9tique M\u00e9dicale, CHU Sainte-Justine, Universit\u00e9 de Montr\u00e9al, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Ann","family":"Thomas","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, University of Calgary, Calgary, Alberta, Canada"},{"name":"Alberta Children\u2019s Hospital Research Institute for Child and Maternal Health, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri J","family":"Stavropoulos","sequence":"additional","affiliation":[{"name":"Genome Diagnostics, Department of Pediatric Laboratory Medicine, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2018,3,1]]},"reference":[{"key":"2025100511405952000_55.4.215.1","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S1701-2163(16)35022-8","article-title":"Use of a DNA method, QF-PCR, in the prenatal diagnosis of fetal aneuploidies","volume":"33","author":"Langlois","year":"2011","journal-title":"J Obstet Gynaecol Can"},{"key":"2025100511405952000_55.4.215.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2010.04.006"},{"key":"2025100511405952000_55.4.215.3","unstructured":"Stavropoulos DJ , Shago M . Genomic microarray testing\u00a0\u2013 CCMG guideline. 2016 https:\/\/www.ccmg-ccgm.org\/images\/job_postngs\/CCMG_Guidelines_for_Genomic_Microarray_Testing_FINAL.pdf (accessed 1 May 2017)."},{"key":"2025100511405952000_55.4.215.4","first-page":"207","article-title":"New grades for recommendations from the Canadian Task Force on Preventive Health Care","volume":"169","author":"Woolf","year":"2003","journal-title":"CMAJ"},{"key":"2025100511405952000_55.4.215.5","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jogc.2016.06.008","article-title":"Joint SOGC-CCMG opinion for reproductive genetic carrier screening: an update for all Canadian providers of maternity and reproductive healthcare in the era of direct-to-consumer testing","volume":"38","author":"Wilson","year":"2016","journal-title":"J Obstet Gynaecol Can"},{"key":"2025100511405952000_55.4.215.6","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/S1701-2163(16)35112-X","article-title":"Use of array genomic hybridization technology in prenatal diagnosis in Canada","volume":"33","author":"Duncan","year":"2011","journal-title":"J Obstet Gynaecol Can"},{"key":"2025100511405952000_55.4.215.7","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/tog.12007","article-title":"The use of chromosomal microarray in prenatal diagnosis","volume":"15","author":"Hillman","year":"2013","journal-title":"Obstet Gynaecol"},{"key":"2025100511405952000_55.4.215.8","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/uog.11092","article-title":"Microarray application in prenatal diagnosis: a position statement from the cytogenetics working group of the Italian Society of Human Genetics (SIGU), November 2011","volume":"39","author":"Novelli","year":"2012","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2025100511405952000_55.4.215.9","unstructured":"Gardiner C , Wellesley D , Kilby MD , Kerr B . Recommendations for the use of chromosome microarray in pregnancy. 2015;2015:1\u201317 https:\/\/www.rcpath.org\/resourceLibrary\/recommendations-for-the-use-of-chromosome-microarray-in-pregnancy.html"},{"key":"2025100511405952000_55.4.215.10","doi-asserted-by":"publisher","DOI":"10.1002\/uog.12575"},{"key":"2025100511405952000_55.4.215.11","doi-asserted-by":"publisher","DOI":"10.1002\/pd.3943"},{"key":"2025100511405952000_55.4.215.12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/uog.14695","article-title":"Array comparative genomic hybridization and fetal congenital heart defects: a systematic review and meta-analysis","volume":"45","author":"Jansen","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2025100511405952000_55.4.215.13","doi-asserted-by":"crossref","unstructured":"Ayr\u00e4s O , Tikkanen M , Eronen M , Paavonen J , Stefanovic V . Increased nuchal translucency and pregnancy outcome: a retrospective study of 1063 consecutive singleton pregnancies in a single referral institution. Prenat Diagn 2013 1 7.","DOI":"10.1002\/pd.4143"},{"key":"2025100511405952000_55.4.215.14","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/uog.14880","article-title":"Genomic microarray in fetuses with increased nuchal translucency and normal karyotype: a systematic review and meta-analysis","volume":"46","author":"Grande","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2025100511405952000_55.4.215.15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1203382"},{"key":"2025100511405952000_55.4.215.16","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1969.00300130131020"},{"key":"2025100511405952000_55.4.215.17","doi-asserted-by":"publisher","DOI":"10.1093\/epirev\/mxr006"},{"key":"2025100511405952000_55.4.215.18","doi-asserted-by":"publisher","DOI":"10.1159\/000226594"},{"key":"2025100511405952000_55.4.215.19","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2012.113"},{"key":"2025100511405952000_55.4.215.20","doi-asserted-by":"publisher","DOI":"10.1002\/pd.4209"},{"key":"2025100511405952000_55.4.215.21","unstructured":"CCMG.\u00a0CCMG Practice Guidelines for Cytogenetic Analysis B. Recommendations for the indications, analysis and reporting of constitutional specimens (peripheral blood, solid tissues) Prepared: CCMG Cytogenetics Committee Approved by CCMG Bo, 2010."},{"key":"2025100511405952000_55.4.215.22","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000000325"},{"key":"2025100511405952000_55.4.215.23","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/uog.14866","article-title":"Diagnostic utility of microarray testing in pregnancy loss","volume":"46","author":"Rosenfeld","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2025100511405952000_55.4.215.24","doi-asserted-by":"publisher","DOI":"10.1002\/pd.3825"},{"key":"2025100511405952000_55.4.215.25","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1002\/ajmg.a.33083","article-title":"Array-based comparative genomic hybridization (aCGH) in the genetic evaluation of stillbirth","volume":"149A","author":"Raca","year":"2009","journal-title":"Am J Med Genet A"},{"key":"2025100511405952000_55.4.215.26","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2350-10-89"},{"key":"2025100511405952000_55.4.215.27","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1159\/000361017","article-title":"Molecular and cytogenetic analysis in stillbirth: results from 481 consecutive cases","volume":"36","author":"Sahlin","year":"2014","journal-title":"Fetal Diagn Ther"},{"key":"2025100511405952000_55.4.215.28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1201569"},{"key":"2025100511405952000_55.4.215.29","doi-asserted-by":"crossref","unstructured":"Wou K , Hyun Y , Chitayat D , Vlasschaert M , Chong K , Wasim S , Keating S , Shannon P , Kolomietz E . Analysis of tissue from products of conception and perinatal losses using QF-PCR and microarray: a three-year retrospective study resulting in an efficient protocol. Eur J Med Genet 2016:1\u20138.","DOI":"10.1016\/j.ejmg.2016.05.011"},{"key":"2025100511405952000_55.4.215.30","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1002\/ajmg.a.31539","article-title":"Detection of low-level mosaicism by array CGH in routine diagnostic specimens","volume":"140","author":"Ballif","year":"2006","journal-title":"Am J Med Genet A"},{"key":"2025100511405952000_55.4.215.31","doi-asserted-by":"publisher","DOI":"10.1002\/pd.1884"},{"key":"2025100511405952000_55.4.215.32","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.cll.2011.08.003","article-title":"Diagnostic implications of excessive homozygosity detected by SNP-based microarrays: consanguinity, uniparental disomy, and recessive single-gene mutations","volume":"31","author":"Kearney","year":"2011","journal-title":"Clin Lab Med"},{"key":"2025100511405952000_55.4.215.33","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddq003"},{"key":"2025100511405952000_55.4.215.34","doi-asserted-by":"publisher","DOI":"10.1097\/GIM.0b013e3182217a3a"},{"key":"2025100511405952000_55.4.215.35","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1007\/s10897-014-9702-y","article-title":"An exploration of genetic counselors' needs and experiences with prenatal chromosomal microarray testing","volume":"23","author":"Bernhardt","year":"2014","journal-title":"J Genet Couns"},{"key":"2025100511405952000_55.4.215.36","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2015-103223"},{"key":"2025100511405952000_55.4.215.37","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2012.164"},{"key":"2025100511405952000_55.4.215.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2014.02.002"},{"key":"2025100511405952000_55.4.215.39","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.33939"},{"key":"2025100511405952000_55.4.215.40","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2011-100372"},{"key":"2025100511405952000_55.4.215.41","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2015-103144"},{"key":"2025100511405952000_55.4.215.42","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2014.151"},{"key":"2025100511405952000_55.4.215.43","doi-asserted-by":"publisher","DOI":"10.1002\/humu.22068"}],"container-title":["Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jmedgenet-2017-105013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T18:41:10Z","timestamp":1759689670000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmg.bmj.com\/lookup\/doi\/10.1136\/jmedgenet-2017-105013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,1]]},"references-count":43,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,3,22]]},"published-print":{"date-parts":[[2018,4]]}},"alternative-id":["10.1136\/jmedgenet-2017-105013"],"URL":"https:\/\/doi.org\/10.1136\/jmedgenet-2017-105013","relation":{},"ISSN":["0022-2593","1468-6244"],"issn-type":[{"value":"0022-2593","type":"print"},{"value":"1468-6244","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,1]]}}}